Watch SBFM. Know when insiders buy.
One email the day a filing lands. Free.
SBFM
Sunshine Biopharma Inc.
2.70
−0.14 −4.93%
USD · close Nov 13
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
13
FLAG · shorts 13
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $10.5MP/E —DIV YIELD —FCF YIELD -51.31%REV TTM $35.3M −2.7%NET INCOME −$5.8MNET CASH $17.7M52W 2.65 – 326.00SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose SBFM in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
Mitchell P. Kopin and 2 related10.0%
BJI Financial Group6.0%
CVI Investments, Inc. and 1 related9.9%
Alta Partners LLC4.9%
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.